⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 16, 2024European Archives of Oto-Rhino-LaryngologyOpen Access

Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics

Elena Cantone Luca D’Ascanio Pietro De Luca Dalila Roccamatisi Ignazio La Mantia Michael Brenner Arianna Di Stadio

View Full Paper

Ask AI

Bookmark

Share

Abstract

Although COVID-19 anosmia is often transient, patients with persistent olfactory dysfunction (pOD) can experience refractory parosmia and diminished smell. This study evaluated four putative therapies for parosmia in patients with chronic COVID-19 olfactory impairment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cantone et al. (2024) studied this question.

synapsesocial.com/papers/68e73b96b6db6435876b5018 https://doi.org/10.1007/s00405-024-08548-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Real-world outcomes of 3-month olfactory training on post-COVID-19 parosmia2025
2Adherence to olfactory training improves orthonasal and retronasal olfaction in post-COVID-19 olfactory loss2024 · 7 citations
3Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment2024 · 6 citations
4Olfactory Training for COVID-19-related Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMeta-Analysis · 2026
5Olfactory Training in the Treatment of COVID-19–Related Olfactory Disorders2025